p21waf1 can block cells at two points in the cell cycle, but does not interfere with processive DNA-replication or stress-activated kinases
The DOI matches its Crossref record.
Abstract
p21waf1 has been shown to mediate the p53-dependent growth arrest induced by DNA-damaging agents. Several functions have been ascribed to p21waf1 that could be involved in this growth arrest. For one, p21waf1 is an efficient inhibitor of cyclin-dependent kinases (CDKs). Also, p21waf1 can interact with proliferating cell nuclear antigen (PCNA), and as such inhibit in vitro DNA-replication. Finally, p21waf1 has been reported to inhibit stress-activated protein kinases (SAPKs). In order to study these multiple functions of p21waf1 we have established U2OS-derived cell lines, in which the expression of p21waf1 can be regulated by the concentration of tetracycline in the culture medium. We observed a virtually complete, but reversible inhibition of cell growth upon induction of p21waf1-expression. Both [3H]thymidine-incorporation and CDK2-activity were strongly inhibited by p21waf1. Upon induction of p21waf1 cells accumulated with a 2N or 4N DNA content suggesting events in G1 and G2 can be inhibited by p21waf1. Indeed, kinase activity associated with cyclin B was reduced dramatically upon induction of p21waf1, although cyclin B continues to be expressed. In contrast, p21waf1 does not seem to inhibit the function of PCNA in ongoing DNA replication, since cells expressing high levels of p21waf1 apparently progressed normally through S-phase. Also, the activity of SAPKs was not substantially affected by the high levels of p21waf1. We conclude that, at least in these U2OS-derived cells, p21waf1 functions as an inhibitor of CDK-activity in G1 and G2, but not as an inhibitor of PCNA or SAPKs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“When assessing the effect of p21 on PCNA-dependent DNA synthesis in cells, several reports showed a limited or null effect of p21–PCNA interaction on DNA replication [38,45,46,47,48,49,50,51].”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [47]
Citations
Cites
Still being checked.
Cited by
p21 in cancer: Intricate networks and multiple activities
Abbas, T., & Dutta, A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2657 · Cited by 2,712
Regulation of the G2/M transition by p53
Taylor, W. R., & Stark, G. R. (2001) · Oncogene · doi:10.1038/sj.onc.1204252 · Cited by 1,559
AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1
Medema, R. H., Kops, G. J. P. L., Bos, J. L., & Burgering, B. M. T. (2000) · Nature · doi:10.1038/35008115 · Cited by 1,438
Self-citationStott, F. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5001 · Cited by 1,167
The p16INK4a/CDKN2A tumor suppressor and its relatives
Ruas, M., & Peters, G. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(98)00017-1 · Cited by 911
Stein, G. H., Drullinger, L. F., Soulard, A., & Dulić, V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.2109 · Cited by 868
Shin, I., Yakes, F. M., Rojo, F., Shin, N.-Y., Bakin, A. V., Baselga, J., & Arteaga, C. L. (2002) · Nature Medicine · doi:10.1038/nm759 · Cited by 790
Dijkers, P. F., Medema, R. H., Pals, C., Banerji, L., Thomas, N. S. B., Lam, E. W.-F., Burgering, B. M. T., Raaijmakers, J. A. M., Lammers, J.-W. J., Koenderman, L., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.24.9138-9148.2000 · Cited by 617
Self-citationCell Cycle Inhibition by FoxO Forkhead Transcription Factors Involves Downregulation of Cyclin D
Schmidt, M., Fernandez de Mattos, S., van der Horst, A., Klompmaker, R., Kops, G. J. P. L., Lam, E. W.-F., Burgering, B. M. T., & Medema, R. H. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.22.7842-7852.2002 · Cited by 562
Self-citationZhan, Q., Antinore, M. J., Wang, X. W., Carrier, F., Smith, M. L., Harris, C. C., & Fornace, A. J. (1999) · Oncogene · doi:10.1038/sj.onc.1202667 · Cited by 474
Bhunia, A. K., Piontek, K., Boletta, A., Liu, L., Qian, F., Xu, P.-N., Germino, F. J., & Germino, G. G. (2002) · Cell · doi:10.1016/s0092-8674(02)00716-x · Cited by 454
FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal
Dijkers, P. F., Birkenkamp, K. U., Lam, E. W.-F., Thomas, N. S. B., Lammers, J.-W. J., Koenderman, L., & Coffer, P. J. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200108084 · Cited by 363
Checking out the G2/M transition
Smits, V. A. J., & Medema, R. H. (2001) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(01)00204-4 · Cited by 355
Self-citationControl of the G2/M Transition
Stark, G. R., & Taylor, W. R. (2006) · Molecular Biotechnology · doi:10.1385/mb:32:3:227 · Cited by 279
Davol, P. A., & Frackelton, A. R. (1999) · The Prostate · doi:10.1002/(sici)1097-0045(19990801)40:3<178::aid-pros6>3.0.co;2-i · Cited by 29
Mechanism of CRL4Cdt2, a PCNA-dependent E3 ubiquitin ligase
Havens, C. G., & Walter, J. C. (2011) · Genes & Development · doi:10.1101/gad.2068611 · Cited by 224
p21 Inhibits Thr161 Phosphorylation of Cdc2 to Enforce the G2 DNA Damage Checkpoint
Smits, V. A. J., Klompmaker, R., Vallenius, T., Rijksen, G., Mäkelä, T. P., & Medema, R. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005437200 · Cited by 221
Self-citationAPC/CCdc20 Controls the Ubiquitin-Mediated Degradation of p21 in Prometaphase
Amador, V., Ge, S., Santamaría, P. G., Guardavaccaro, D., & Pagano, M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.06.013 · Cited by 209
Fang, L., Igarashi, M., Leung, J., Sugrue, M. M., Lee, S. W., & Aaronson, S. A. (1999) · Oncogene · doi:10.1038/sj.onc.1202615 · Cited by 207
Ando, T., Kawabe, T., Ohara, H., Ducommun, B., Itoh, M., & Okamoto, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106460200 · Cited by 202
Stark, G. R., & Taylor, W. R. (2004) · Checkpoint Controls and Cancer · doi:10.1385/1-59259-788-2:051 · Cited by 195
Lee, M.-H., & Yang, H.-Y. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000826 · Cited by 192
Gali-Muhtasib, H. U., Abou Kheir, W. G., Kheir, L. A., Darwiche, N., & Crooks, P. A. (2004) · Anti-Cancer Drugs · doi:10.1097/00001813-200404000-00012 · Cited by 187
Barnouin, K., Dubuisson, M. L., Child, E. S., Fernandez de Mattos, S., Glassford, J., Medema, R. H., Mann, D. J., & Lam, E. W.-F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111123200 · Cited by 161
Self-citationLi, X., Wang, G., Zhao, J., Ding, H., Cunningham, C., Chen, F., Flynn, D. C., Reed, E., & Li, Q. Q. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5027-1 · Cited by 155
Tumor suppressor p53: regulation and function
Somasundaram, K. (2000) · Frontiers in bioscience · doi:10.2741/somasund · Cited by 175
Epperly, M. W., Gretton, J. E., Sikora, C. A., Jefferson, M., Bernarding, M., Nie, S., & Greenberger, J. S. (2003) · Radiation Research · doi:10.1667/rr3081 · Cited by 150
F. Lavin, K. K. K. (1999) · International Journal of Radiation Biology · doi:10.1080/095530099139359 · Cited by 136
Emerging role of nuclear protein 1 (NUPR1) in cancer biology
Chowdhury, U. R., Samant, R. S., Fodstad, Ø., & Shevde, L. A. (2009) · Cancer and Metastasis Reviews · doi:10.1007/s10555-009-9183-x · Cited by 131
p53 directly transactivates Δ133p53α, regulating cell fate outcome in response to DNA damage
Aoubala, M., Murray-Zmijewski, F., Khoury, M. P., Fernandes, K., Perrier, S., Bernard, H., Prats, A.-C., Lane, D. P., & Bourdon, J.-C. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2010.91 · Cited by 131
Romanov, V. S., Pospelov, V. A., & Pospelova, T. V. (2012) · Biochemistry (Moscow) · doi:10.1134/s000629791206003x · Cited by 123
Uncoupling protein-2 deficiency promotes oxidant stress and delays liver regeneration in mice
Horimoto, M., Fülöp, P., Derdák, Z., Wands, J. R., & Baffy, G. (2004) · Hepatology · doi:10.1002/hep.20047 · Cited by 120
Less understood issues: p21Cip1 in mitosis and its therapeutic potential
Kreis, N., Louwen, F., & Yuan, J. (2014) · Oncogene · doi:10.1038/onc.2014.133 · Cited by 129
Li, Y., Li, X., & Guo, B. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1924 · Cited by 116
CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication
Mansilla, S. F., De La Vega, M. B., Calzetta, N. L., Siri, S. O., & Gottifredi, V. (2020) · Genes · doi:10.3390/genes11060593 · Cited by 114
“Consistently, we and others showed that pol δ recruitment to PCNA is unaltered by changes in endogenous p21 expression [47,54,55,88].”
BackgroundZhang, X., Xu, L., Wang, Z., Wang, K., Li, N., Cheng, Z., Huang, S., Dong-zhi, W., & Han, Z. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.06.010 · Cited by 112
Schneider‐Stock, R., Diab-Assef, M., Rohrbeck, A., Foltzer‐Jourdainne, C., Boltze, C., Hartig, R., Schönfeld, P., Roessner, A., & Gali‐Muhtasib, H. U. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.074195 · Cited by 121
RetractedSoria, G., Speroni, J., Podhajcer, O. L., Prives, C., & Gottifredi, V. (2008) · Journal of Cell Science · doi:10.1242/jcs.027730 · Cited by 94
Yang, D., Tan, M., Wang, G., & Sun, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034079 · Cited by 99
Clark, D., Mitra, A., Fillmore, R., Jiang, W., Samant, R., Fodstad, O., & Shevde, L. (2008) · Current Cancer Drug Targets · doi:10.2174/156800908785133196 · Cited by 89
Fukuda, S., Mantel, C., & Pelus, L. M. (2003) · Blood · doi:10.1182/blood-2003-05-1756 · Cited by 94
Identification of a Functional Domain in a GADD45-mediated G2/M Checkpoint
Yang, Q., Manicone, A. M., Coursen, J. D., Linke, S. P., Nagashima, M., Forgues, M., & Wang, X. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005319200 · Cited by 95
Eupatilin, a dietary flavonoid, induces G2/M cell cycle arrest in human endometrial cancer cells
Cho, J.-H., Lee, J.-G., Yang, Y., Kim, J., Ahn, J., Baek, N., Lee, K., & Choi, J. (2011) · Food and Chemical Toxicology · doi:10.1016/j.fct.2011.04.019 · Cited by 85
p53 inhibits entry into mitosis when DNA synthesis is blocked
Taylor, W. R., Agarwal, M. L., Agarwal, A. M., Stacey, D. W., & Stark, G. R. (1999) · Oncogene · doi:10.1038/sj.onc.1202516 · Cited by 90
Genistein elicits pleiotropic molecular effects on head and neck cancer cells.
Alhasan, S., Aranha, O., & Sarkar, F. H. (2001) · PubMed · Cited by 79
The Wnts of change: How Wnts regulate phenotype switching in melanoma
Webster, M. R., Kugel, C. H., & Weeraratna, A. T. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.10.002 · Cited by 94
Involvement of p21 in the PKC‐induced regulation of the G2/M cell cycle transition
Barboule, N., Lafon, C., Chadebech, P., Vidal, S., & Valette, A. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00022-8 · Cited by 81
Liu, L., Yin, Y., Li, Y., Prevedel, L., Lacy, E., Ma, L., & Zhou, P. (2012) · Cell Research · doi:10.1038/cr.2012.48 · Cited by 67
Ito, T., Tsukumo, S., Suzuki, N., Motohashi, H., Yamamoto, M. P., Fujii‐Kuriyama, Y., Mimura, J., Lin, T.-M., Peterson, R. E., Tohyama, C., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402143200 · Cited by 83
DNA Damage Triggers p21WAF1-dependent Emi1 Down-Regulation That Maintains G2 Arrest
Lee, J., Kim, J. A., Barbier, V., Fotedar, A., & Fotedar, R. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-08-0818 · Cited by 68
“A role of p21WAF1 in G2 arrest was suggested by studies in which the ectopic expression of p53 or p21WAF1 (hereafter referred to as p21) led to an arrest in both G1 and G2 phases of the cell cycle (Agarwal et al., 1995; Bates et al., 1998; Medema et al., 1998; Niculescu et al., 1998).”
BackgroundEpperly, M. W., Bernarding, M., Gretton, J. E., Jefferson, M., Nie, S., & Greenberger, J. S. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00041-9 · Cited by 70
Cdc25C interacts with PCNA at G2/M transition
Kawabe, T., Suganuma, M., Ando, T., Kimura, M., Hori, H., & Okamoto, T. (2002) · Oncogene · doi:10.1038/sj.onc.1205229 · Cited by 70
Cytokine response gene 6 induces p21 and regulates both cell growth and arrest
Fan, W., Richter, G. H. S., Cereseto, A., Beadling, C., & Smith, K. A. (1999) · Oncogene · doi:10.1038/sj.onc.1203054 · Cited by 65
The mysterious human epidermal cell cycle, or an oncogene-induced differentiation checkpoint
Gandarillas, A. (2012) · Cell Cycle · doi:10.4161/cc.22529 · Cited by 68
Xie, Y., Zhang, H., Sheng, W., Xiang, J., Ye, Z., & Yang, J. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.05.050 · Cited by 69
Ito, K., Nakazato, T., Miyakawa, Y., Yamato, K., Ikeda, Y., & Kizaki, M. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10289 · Cited by 62
van Oirschot, B. A., Stahl, M., Lens, S. M. A., & Medema, R. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104395200 · Cited by 66
Self-citationDifferential modulation of paclitaxel-mediated apoptosis by p21Waf1 and p27Kip1
Schmidt, M., Lü, Y., Liu, B., Fang, M., Mendelsohn, J. M., & Fan, Z. (2000) · Oncogene · doi:10.1038/sj.onc.1203546 · Cited by 62
Jazirehi, A. R. (2010) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32833dad91 · Cited by 67
Chowdhury, I. H., Wang, X., Landau, N. R., Robb, M. L., Polonis, V. R., Birx, D. L., & Kim, J. H. (2003) · Virology · doi:10.1006/viro.2002.1777 · Cited by 69
p21CIP1 Is Dispensable for the G2 Arrest Caused by Genistein in Human Melanoma Cells
Casagrande, F., & Darbon, J.-M. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4914 · Cited by 63
Apoptotic Events in a Human Ovarian Cancer Cell Line Exposed to Anthracyclines
Bellarosa, D., Ciucci, A., Bullo, A., Nardelli, F., Manzini, S., Maggi, C. A., & Goso, C. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38772-5 · Cited by 55
Wei, J., Zhao, J., Long, M., Han, Y., Wang, X., Lin, F., Ren, J., He, T., & Zhang, H. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-632 · Cited by 53
Ostrakhovitch, E. A., & Cherian, M. G. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.01.004 · Cited by 60
ΔMEKK3:ER* activation induces a p38α/β2-dependent cell cycle arrest at the G2 checkpoint
Garner, A. P., Weston, C. R., Todd, D. E., Balmanno, K., & Cook, S. J. (2002) · Oncogene · doi:10.1038/sj.onc.1206000 · Cited by 52
The changing face of p53 in head and neck cancer
Partridge, M., Costea, D. E., & Huang, X. (2007) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.ijom.2007.06.006 · Cited by 56
McVean, M., Weinberg, W. C., & Pelling, J. C. (2002) · Molecular Carcinogenesis · doi:10.1002/mc.10016 · Cited by 49
Slagsvold, J. E., Pettersen, C. H. H., Størvold, G. L., Follestad, T., Krokan, H. E., & Schønberg, S. A. (2010) · Nutrition and Cancer · doi:10.1080/01635580903532366 · Cited by 54
Chen, D., Chen, Z., Park, C., McCarthy, T. L., Chen, L., Alomari, A. K., & Moeckel, G. W. (2013) · Gene · doi:10.1016/j.gene.2013.08.047 · Cited by 54
Cyclin D3 Regulates Proliferation and Apoptosis of Leukemic T Cell Lines
Boonen, G. J. J. C., van Oirschot, B. A., van Diepen, A., Mackus, W. J. M., Verdonck, L. F., Rijksen, G., & Medema, R. H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.34676 · Cited by 48
Self-citationCyclin E drives human keratinocyte growth into differentiation
Freije, A., Ceballos, L., Coisy‐Quivy, M., Barnes, L., Rosa‐Garrido, M., de Diego, E., Blanchard, J., & Gandarillas, A. (2012) · Oncogene · doi:10.1038/onc.2012.22 · Cited by 49
Lee, J.-G., Kim, J., Ahn, J., Lee, K., Baek, N., & Choi, J. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.12.026 · Cited by 45
p21Waf1/Cip1 deficiency causes multiple mitotic defects in tumor cells
Kreis, N., Sanhaji, M., Rieger, M. A., Louwen, F., & Yuan, J. (2013) · Oncogene · doi:10.1038/onc.2013.518 · Cited by 48
Wright, D. G., Marchal, C., Hoang, K., Ankney, J. A., Nguyen, S. T., Rushing, A. W., Polakowski, N., Miotto, B., & Lemasson, I. (2016) · Oncotarget · doi:10.18632/oncotarget.6424 · Cited by 44
Modestou, M., Puig-Antich, V., Korgaonkar, C. K., Eapen, A. K., & Quelle, D. E. (2001) · PubMed · Cited by 48
Activity of the Heat Shock Protein 90 Inhibitor Ganetespib in Melanoma
Wu, X., Marmarelis, M. E., & Hodi, F. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056134 · Cited by 45
A theory for controlling cell cycle dynamics using a reversibly binding inhibitor
Gardner, T. S., Dolnik, M., & Collins, J. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14190 · Cited by 45
SIAH-1 inhibits cell growth by altering the mitotic process
Bruzzoni‐Giovanelli, H., Faille, A., Linares‐Cruz, G., Nemani, M., Deist, F. L., Germani, A., Chassoux, D. M., Millot, G., Roperch, J.-P., Amson, R. B., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1203187 · Cited by 41
Moshnikova, A., Afanasyev, V. N., Proussakova, O. V., Chernyshov, S. V., Gogvadze, V. G., & Петрович, Б. И. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5383-x · Cited by 40
p53-dependent effects of RAS oncogene on chromosome stability and cell cycle checkpoints
Agapova, L. S., Ivanov, A., Sablina, A. A., Kopnin, P., Oi, S., Chumakov, P. M., & Kopnin, B. P. (1999) · Oncogene · doi:10.1038/sj.onc.1202386 · Cited by 43
Qin, L. F., & Ng, I. O. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00701-7 · Cited by 40
Schmidt, M., Lu, Y., Parant, J. M., Lozano, G., Bacher, G., Beckers, T. L., & Fan, Z. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.5.900 · Cited by 42
LncRNA LINC00341 mediates PM 2.5 -induced cell cycle arrest in human bronchial epithelial cells
Xu, Y., Wu, J., Peng, X., Yang, T., Liu, M., Chen, L., Dai, X., Wang, Z., Yang, C., Yan, B., et al. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2017.03.026 · Cited by 39
Infection, mutation, and cancer evolution
Ewald, P. W., & Ewald, H. A. S. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0891-2 · Cited by 39
Inhibition of cell proliferation by the PCNA-binding region of p21 expressed as a GFP miniprotein.
Mattock, H., Lane, D., & Warbrick, E. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5160 · Cited by 38
p21 response to DNA damage induced by genistein and etoposide in human lung cancer cells
Ding, H., Duan, W., Zhu, W., Ju, R., Srinivasan, K., Otterson, G. A., & Villalona-Calero, M. A. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00873-8 · Cited by 43
IGF-II Enhances Trichostatin A-Induced TGFβ1 and p21Waf1,Cip1,Sdi1 Expression in Hep3B Cells
Gray, S. G., Yakovleva, T., Hartmann, W., Tally, M., Bakalkin, G. Y., & Ekström, T. J. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4661 · Cited by 37
Xie, Y. F., Sheng, W., Xiang, J., Zhang, H., Ye, Z., & Yang, J. (2009) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2008.0582 · Cited by 40
Tumor Suppressor SMAR1 Activates and Stabilizes p53 through Its Arginine-Serine-rich Motif
Jalota, A., Singh, K., Chavali, P. L., Kaul-Ghanekar, R., Jameel, S., & Chattopadhyay, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413200200 · Cited by 39
RetractedSchmidt, A.-K., Pudelko, K., Boekenkamp, J.-E., Berger, K., Kschischo, M., & Bastians, H. (2020) · Oncogene · doi:10.1038/s41388-020-01524-4 · Cited by 38
Choi, H. J., Yee, S.-B., Park, S.-E., Im, E., Jung, J. H., Chung, H. Y., Choi, Y. H., & Kim, N. D. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.02.030 · Cited by 33
Hayashi, T., Hayashi, I., Shinohara, T., Morishita, Y., Nagamura, H., Kusunoki, Y., Kyoizumi, S., Seyama, T., & Nakachi, K. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.07.002 · Cited by 38
Aebersold, D. M., Kollár, A., Beer, K. T., Laissue, J. A., Greiner, R. H., & Djonov, V. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010220)96:1<1::aid-ijc1>3.0.co;2-d · Cited by 85
Lee, S. M., Kwon, J. I., Choi, Y. H., Eom, H. S., & Chi, G. Y. (2008) · Phytotherapy Research · doi:10.1002/ptr.2355 · Cited by 31
Malashicheva, A., Kislyakova, T., Aksenov, N., Osipov, K. A., & Pospelov, V. A. (2000) · Oncogene · doi:10.1038/sj.onc.1203736 · Cited by 37
Zinc-induced G2/M blockage is p53 and p21 dependent in normal human bronchial epithelial cells
Wong, S. H. K., Shih, R. S. M., Schoene, N. W., & Lei, K. Y. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00061.2008 · Cited by 30
Lin, C., Kuo, H.-H., Chen, J., Yang, C., & Wang, W.-B. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4121 · Cited by 33
Negative Growth Regulation of SK-N-MC Cells by bFGF Defines a Growth Factor-sensitive Point in G2
Smits, V. A. J., van Peer, M. A., Essers, M. A. G., Klompmaker, R., Rijksen, G., & Medema, R. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001764200 · Cited by 30
Self-citationRaab, M., Kostova, I., Peña‐Llopis, S., Fietz, D., Kressin, M., Aberoumandi, S. M., Ullrich, E., Becker, S., Sanhaji, M., & Strebhardt, K. (2023) · 癌症:英文版 · doi:10.1002/cac2.12511 · Cited by 31
McGrath‐Morrow, S. A., & Stahl, J. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(00)00142-7 · Cited by 27
Metadata
- Authors
- Medema, R. H., Klompmaker, R., Smits, V. A., & Rijksen, G.
- Affiliations
- University Medical Center Utrecht (NL)
- Venue
- Oncogene
- Published
- 1998-01-29
- Volume
- 16
- Issue
- 4
- Pages
- 431-441
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1982060264
- Cited by
- 161
- References
- 0
- Citations by year
- 2026: 1 · 2023: 2 · 2021: 2 · 2020: 4 · 2019: 1 · 2018: 1 · 2017: 3 · 2016: 1 · 2015: 3 · 2014: 2 · 2013: 4 · 2012: 12
- FWCI
- 7.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Funders
- KWF Kankerbestrijding
- National Institutes of Health (5r35ca039826-10)
- National Cancer Institute (CA 39826)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- p21, cell cycle arrest, cyclin-dependent kinase inhibition, CDK2, cyclin B, proliferating cell nuclear antigen, DNA replication, c-Jun N-terminal kinase, tetracycline-regulated expression
- MeSH terms
- Antineoplastic Agents, Phytogenic, Camptothecin, Cell Division, DNA Damage, DNA Replication, DNA, Neoplasm, Flow Cytometry, Humans, Mitosis, Ploidies, Protein Kinases, Protein Synthesis Inhibitors, Tetracycline, Transfection, Tumor Cells, Cultured, Transcriptional Activation, G1 Phase, G2 Phase, S Phase, Cyclins, Protein Serine-Threonine Kinases, Proliferating Cell Nuclear Antigen, Cyclin-Dependent Kinases, Cyclin B, Cyclin-Dependent Kinase Inhibitor p16, CDC2-CDC28 Kinases, Cyclin-Dependent Kinase Inhibitor p21, Cyclin-Dependent Kinase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.